O Lozano-Castañeda

400 total citations
10 papers, 280 citations indexed

About

O Lozano-Castañeda is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, O Lozano-Castañeda has authored 10 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Physiology and 2 papers in Surgery. Recurrent topics in O Lozano-Castañeda's work include Diabetes Treatment and Management (3 papers), Diabetes Management and Research (3 papers) and Pancreatic function and diabetes (2 papers). O Lozano-Castañeda is often cited by papers focused on Diabetes Treatment and Management (3 papers), Diabetes Management and Research (3 papers) and Pancreatic function and diabetes (2 papers). O Lozano-Castañeda collaborates with scholars based in United States and Mexico. O Lozano-Castañeda's co-authors include Alexander Marble, Rafael A. Camerini-Dávalos, Juan Rull, Jorge González‐Barranco, Francisco J. Gómez‐Pérez, Searle B. Rees, James Caulfield, James A. Bougas, Harry N. Antoniades and Leo P. Krall and has published in prestigious journals such as New England Journal of Medicine, Diabetes and Pain.

In The Last Decade

O Lozano-Castañeda

10 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O Lozano-Castañeda United States	5	131	76	62	48	45	10	280
Page Ih	11	66 0.5×	52 0.7×	10 0.2×	17 0.4×	57 1.3×	27	361
Jeff Mahon Canada	8	70 0.5×	76 1.0×	43 0.7×	10 0.2×	17 0.4×	12	275
Smith Ee	8	37 0.3×	33 0.4×	29 0.5×	5 0.1×	40 0.9×	15	315
Gries Fa Germany	10	125 1.0×	120 1.6×	8 0.1×	39 0.8×	27 0.6×	39	344
J. H. Sunder United States	11	61 0.5×	168 2.2×	9 0.1×	16 0.3×	59 1.3×	34	310
Giuseppe Bellini Italy	11	71 0.5×	117 1.5×	37 0.6×	29 0.6×	52 1.2×	22	339
R F Fletcher United Kingdom	13	91 0.7×	149 2.0×	61 1.0×	28 0.6×	40 0.9×	21	443
P J Hale United Kingdom	11	114 0.9×	170 2.2×	32 0.5×	9 0.2×	54 1.2×	27	355
Nancy J. Holaday United States	12	110 0.8×	115 1.5×	24 0.4×	12 0.3×	41 0.9×	21	340
H. David Watts United States	8	136 1.0×	111 1.5×	14 0.2×	34 0.7×	23 0.5×	9	442

Countries citing papers authored by O Lozano-Castañeda

Since Specialization

Citations

This map shows the geographic impact of O Lozano-Castañeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Lozano-Castañeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Lozano-Castañeda more than expected).

Fields of papers citing papers by O Lozano-Castañeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Lozano-Castañeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Lozano-Castañeda. The network helps show where O Lozano-Castañeda may publish in the future.

Co-authorship network of co-authors of O Lozano-Castañeda

This figure shows the co-authorship network connecting the top 25 collaborators of O Lozano-Castañeda. A scholar is included among the top collaborators of O Lozano-Castañeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Lozano-Castañeda. O Lozano-Castañeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Gómez‐Pérez, Francisco J., et al.. (1985). Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study. Pain. 23(4). 395–400. 122 indexed citations

2.

Bordes, Joeri, et al.. (1975). A neurohumoral link in the initial hyperglycemic response to food ingestion.. PubMed. 26(4). 299–308. 1 indexed citations

3.

Schulte, Joann, et al.. (1974). [Long-term (3 year) results of the treatment of stable diabetes with low doses of chlopropamide-metformin].. PubMed. 38(7). 281–2. 4 indexed citations

4.

Lozano-Castañeda, O, et al.. (1971). [Chlorpropamide-metformin in obese diabetics or diabetics with side effects from sulfonylureas. 2-year results].. PubMed. 36(7). 347–9. 4 indexed citations

5.

Rull, Juan, et al.. (1970). Over-all Therapeutic Usefulness of Glybenclamide, a New Hypoglycemic Sulfonylurea. Diabetes. 19(4). 264–270. 4 indexed citations

6.

Lozano-Castañeda, O, et al.. (1970). Metabolic Studies in Prediabetic Subjects. Elsevier eBooks. 1. 315–320. 1 indexed citations

7.

Lozano-Castañeda, O, Rafael A. Camerini-Dávalos, Leo P. Krall, & Alexander Marble. (1964). Two years' experience with acetohexamide. Metabolism. 13(2). 99–106. 7 indexed citations

8.

Antoniades, Harry N., et al.. (1963). Insulin-Regulatory Mechanisms and Diabetes Mellitus. New England Journal of Medicine. 269(8). 386–390. 38 indexed citations

9.

Camerini-Dávalos, Rafael A., et al.. (1963). Preliminary Observations on Subjects with Prediabetes. Diabetes. 12(6). 508–518. 92 indexed citations

10.

Camerini-Dávalos, Rafael A., O Lozano-Castañeda, & Alexander Marble. (1962). Five years' experience with tolbutamide.. PubMed. 11(Suppl). 74–80. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact